LSO's advocacy efforts currently focus around three key priorities:
- The need for a coordinated provincial life sciences strategy aligning with a clear vision for Canada’s life sciences sector.
- Support for innovation – including policy surrounding potential changes to drug pricing and intellectual property impacting the health of Canadians and the sustainability of our healthcare system.
- Access to capital and support for talent so our life sciences companies can thrive and grow here at home, creating Made-in-Ontario success stories.
Blueprint for a Coordinated Ontario Life Sciences Strategy
LSO has campaigned strongly for a provincial life sciences strategy that will provide a roadmap to accelerate our sector.
To that end, we created our Blueprint for a Coordinated Ontario Life Sciences Strategy, launched at our Annual Policy Forum in December 2017. It lays out a comprehensive plan and recommendations for policymakers to accelerate the success of life sciences, with specific action around promotion of our sector, access to capital, talent growth, and support for innovation. The document was endorsed by leading provincial and national life sciences, health, and economic organizations
Download your copy of the Blueprint.